Genetic Signatures
Biotechnology ResearchNew South Wales, Australia51-200 Employees
Genetic Signatures is an established, global molecular diagnostics company, specialising in syndromic multiplex real-time PCR testing to provide configurable, clinically relevant MDx solutions for infectious diseases. A diverse range of assays are available under the EasyScreen™ brand, for the flexible detection of over 100 pathogens impacting global health. The EasyScreen™ kits are underpinned by Genetic Signatures’ innovative 3base™ technology, which transforms natural genetic sequences into a 3base™ sequence of A, T and C which improves multiplex efficiency and reduces the genetic complexity of detecting pathogens. This is particularly beneficial for detecting pathogen subtypes and providing increased resistance to mutation or variants, such as SARS-CoV-2. Genetic Signatures’ flexible syndromic approach provides a timely and accurate diagnosis that enhances efficiencies within the laboratory. Customers trust Genetic Signatures’ assay and workflow reliability which is supported by the Company’s high service standards and genuine partnership for driving improved patient outcomes. Genetic Signatures’ EasyScreen™ products are accessible in over 30 countries, with direct representation in the United States, United Kingdom, Germany, and Australia, and distribution partners in Canada, South America, Africa and other European nations. Products are used for IVD use and research purposes. As an employer, Genetic Signatures is proud of their highly rated and diverse workplace culture, and is committed to providing equal employment opportunities and professional development. Visit www.geneticsignatures.com for more information or email marketing@geneticsignatures.com to contact your local specialist. #moleculardiagnostics #pathology #PCR #multiplex #infectiousdisease #3base